Alto issues Sales Agreement August 2026
Alto granted authority for an at-the-market offering of up to $50 million shares. This authorization influences liquidity and cap table management.
View filing at SEC.gov →4 most recent filings and news items mentioning ALTO. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/ALTO/news?limit=20"
Pull ALTO filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayAlto granted authority for an at-the-market offering of up to $50 million shares. This authorization influences liquidity and cap table management.
View filing at SEC.gov →Alto Ingredients reported a Q2 2026 net income of $11.4 million marked by a significant increase in net income and adjusted EBITDA compared to the prior year, aided by earnings from 45Z tax credits.
View filing at SEC.gov →Alto Neuroscience Inc. confirmed an agreement with BofA Securities to sell 3.77 million common shares. This filing outlines the terms for the registered direct offering of new equity.
View filing at SEC.gov →Alto Ingredients filed a document outlining its 2026 Omnibus Incentive Plan to replace the predecessor plan. This provides stock-based awards to key personnel, signaling the company's strategy to attract and retain talent.
View filing at SEC.gov →